Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
European Journal of Endocrinology|November 6, 2008
Treatment of Nelson's syndrome with temozolomideV J Moyes, G Alusi, H I Sabin, et al.
Clinical Endocrinology|August 25, 2005
Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacementT T Chung, W M Drake, J Evanson, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
Effective combination treatment with cabergoline and low-dose pegvisomant in active acromegaly: a prospective clinical trialC E Higham, A B Atkinson, S Aylwin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2006
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegalyA N Paisley, C J O'Callaghan, K C Lewandowski, et al.
Clinical Endocrinology|December 31, 2009
d3-GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adultsV J Moyes, D M Walker, S Owusu-Antwi, et al.
British Journal of Cancer|July 18, 2013
Sequelae and survivorship in patients treated with (131)I-MIBG therapyW C C Sze, A B Grossman, I Goddard, et al.
Clinical Endocrinology|March 14, 1998
Metastatic parathyroid carcinoma in the MEN2A syndromeP J Jenkins, M A Satta, M Simmgen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1998
Optimizing growth hormone replacement therapy by dose titration in hypopituitary adultsW M Drake, D Coyte, C Camacho-Hübner, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2017
Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronismM J Hannon, W C Sze, R Carpenter, et al.
Pageof 8